Vistin Pharma ASA VP4.F Stock
Vistin Pharma ASA Price Chart
Vistin Pharma ASA VP4.F Financial and Trading Overview
Vistin Pharma ASA stock price | 1.9 EUR |
Previous Close | 2.07 EUR |
Open | 2.07 EUR |
Bid | 2.06 EUR x N/A |
Ask | 2.1 EUR x N/A |
Day's Range | 2.07 - 2.07 EUR |
52 Week Range | 1.08 - 2.1 EUR |
Volume | 1.53K EUR |
Avg. Volume | 36 EUR |
Market Cap | 92.02M EUR |
Beta (5Y Monthly) | 1.074712 |
PE Ratio (TTM) | 207 |
EPS (TTM) | 0.11 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 21, 2021 |
1y Target Est | N/A |
VP4.F Valuation Measures
Enterprise Value | 108.72M EUR |
Trailing P/E | 207 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.24699624 |
Price/Book (mrq) | 0.33962265 |
Enterprise Value/Revenue | 0.292 |
Enterprise Value/EBITDA | 2.886 |
Trading Information
Vistin Pharma ASA Stock Price History
Beta (5Y Monthly) | 1.074712 |
52-Week Change | 29.23% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.1 EUR |
52 Week Low | 1.08 EUR |
50-Day Moving Average | 1.82 EUR |
200-Day Moving Average | 1.54 EUR |
VP4.F Share Statistics
Avg. Volume (3 month) | 36 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 44.34M |
Float | 18.85M |
Short Ratio | N/A |
% Held by Insiders | 55.14% |
% Held by Institutions | 12.08% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.75 |
Trailing Annual Dividend Yield | 36.23% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.00% |
Operating Margin (ttm) | 6.65% |
Gross Margin | 55.60% |
EBITDA Margin | 10.10% |
Management Effectiveness
Return on Assets (ttm) | 4.40% |
Return on Equity (ttm) | 2.80% |
Income Statement
Revenue (ttm) | 372.57M EUR |
Revenue Per Share (ttm) | 8.4 EUR |
Quarterly Revenue Growth (yoy) | 203.90% |
Gross Profit (ttm) | 166.79M EUR |
EBITDA | 37.67M EUR |
Net Income Avi to Common (ttm) | 7.46M EUR |
Diluted EPS (ttm) | 0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.06M EUR |
Total Cash Per Share (mrq) | 0.07 EUR |
Total Debt (mrq) | 27.08M EUR |
Total Debt/Equity (mrq) | 10.02 EUR |
Current Ratio (mrq) | 1.401 |
Book Value Per Share (mrq) | 6.095 |
Cash Flow Statement
Operating Cash Flow (ttm) | 17.05M EUR |
Levered Free Cash Flow (ttm) | -33130750 EUR |
Profile of Vistin Pharma ASA
Country | Germany |
State | N/A |
City | Oslo |
Address | OestensjOeveien 27 |
ZIP | 0661 |
Phone | 47 35 98 42 00 |
Website | https://www.vistin.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 77 |
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.
Q&A For Vistin Pharma ASA Stock
What is a current VP4.F stock price?
Vistin Pharma ASA VP4.F stock price today per share is 1.9 EUR.
How to purchase Vistin Pharma ASA stock?
You can buy VP4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vistin Pharma ASA?
The stock symbol or ticker of Vistin Pharma ASA is VP4.F.
Which industry does the Vistin Pharma ASA company belong to?
The Vistin Pharma ASA industry is Drug Manufacturers-Specialty & Generic.
How many shares does Vistin Pharma ASA have in circulation?
The max supply of Vistin Pharma ASA shares is 45.1M.
What is Vistin Pharma ASA Price to Earnings Ratio (PE Ratio)?
Vistin Pharma ASA PE Ratio is 17.22727200 now.
What was Vistin Pharma ASA earnings per share over the trailing 12 months (TTM)?
Vistin Pharma ASA EPS is 0.11 EUR over the trailing 12 months.
Which sector does the Vistin Pharma ASA company belong to?
The Vistin Pharma ASA sector is Healthcare.